129 related articles for article (PubMed ID: 25785949)
1. Focus on early detection to reduce melanoma deaths.
Geller AC; Swetter SM; Weinstock MA
J Invest Dermatol; 2015 Apr; 135(4):947-949. PubMed ID: 25785949
[TBL] [Abstract][Full Text] [Related]
2. More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.
Whiteman DC; Baade PD; Olsen CM
J Invest Dermatol; 2015 Apr; 135(4):1190-1193. PubMed ID: 25330295
[No Abstract] [Full Text] [Related]
3. [Lymphocytes and fibrinolysis in men and women with skin melanoma].
Sokolova II; Bergut FA; Repina FB
Vestn Dermatol Venerol; 1980 Jul; (7):15-9. PubMed ID: 7405390
[No Abstract] [Full Text] [Related]
4. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis based on death rate in relation to irritation, growth, and surface structure of primary focus in malignant melanoma].
Heite HJ
Arch Dermatol Forsch; 1972; 244():200-5. PubMed ID: 4648687
[No Abstract] [Full Text] [Related]
6. Kinetic model of progression of cutaneous melanoma population.
Gutkowicz-Krusin D; Rabinovitz HS
Melanoma Res; 2007 Dec; 17(6):354-9. PubMed ID: 17992117
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.
Woodcock JL; Eyre ZW; Stoddard GJ; Callis Duffin K; Bowen AR
J Am Acad Dermatol; 2017 Oct; 77(4):766-768. PubMed ID: 28917460
[No Abstract] [Full Text] [Related]
8. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
Claeson M; Gillstedt M; Whiteman DC; Paoli J
Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
[TBL] [Abstract][Full Text] [Related]
9. Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.
Jones MS; Torisu-Itakura H; Flaherty DC; Schoellhammer HF; Lee J; Sim MS; Faries MB
Am Surg; 2016 Oct; 82(10):1009-1013. PubMed ID: 27779995
[TBL] [Abstract][Full Text] [Related]
10. Progress and prospects on melanoma: the way forward for early detection and reduced mortality.
Weinstock MA
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2297s-2300s. PubMed ID: 16609048
[TBL] [Abstract][Full Text] [Related]
11. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
12. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?
Rowe CJ; Khosrotehrani K
Australas J Dermatol; 2016 Aug; 57(3):175-81. PubMed ID: 26010424
[TBL] [Abstract][Full Text] [Related]
14. Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia.
Mar V; Roberts H; Wolfe R; English DR; Kelly JW
J Am Acad Dermatol; 2013 Apr; 68(4):568-575. PubMed ID: 23182058
[TBL] [Abstract][Full Text] [Related]
15. Reducing mortality in individuals at high risk for advanced melanoma through education and screening.
Geller AC; Swetter SM; Oliveria S; Dusza S; Halpern AC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S87-94. PubMed ID: 22018072
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and the prognosis of malignant melanoma.
Grin CM; Driscoll MS; Grant-Kels JM
Semin Oncol; 1996 Dec; 23(6):734-6. PubMed ID: 8970595
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
18. Melanoma survival is superior in females across all tumour stages but is influenced by age.
Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
[TBL] [Abstract][Full Text] [Related]
19. Targeting early detection of malignant melanoma of the skin.
Cooke KR; McNoe BM
N Z Med J; 1990 Nov; 103(902):551-3. PubMed ID: 2243650
[TBL] [Abstract][Full Text] [Related]
20. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
